Login
← Go Back
Syngene International
SYNGENE · Pharma > Pharmaceuticals & Drugs · Chairman: Kiran Mazumdar Shaw · MD: Jonathan Hunt · Listing date: Aug. 11, 2015 · Employees: 5437 · Bangalore · http://www.syngeneintl.com
Stock Price vs Company Growth
1d
1.0%
1w
1.3%
1m
3.7%
3m
10.0%
6m
30.6%
1y
30.8%
5y
4.8%
10y
8.7%
all
10.4%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 449 1.0%
380
518
Company Overview
Sales
3,739 Cr
Growth: 2.8%
Profit after Tax
317 Cr
Growth: -10.1%
Mid Cap
18,115 Cr
P/E: 57.1x
Industry P/E: 31.3x
Fundamentals
Sales (Cr) ₹ 3,739
Growth 2.8%
EBITDA 24.6%
P/S 4.8x
Dividend 0.2%
P/E 57.1x
Book Value ₹ 120
PEG Ratio 20.3x
ROE 6.5%
P/B 3.7x
Shareholding Pattern
Institutions
Government Pension Fund Global
1.14 %
Uti-Mid Cap Fund
1.03 %
Qualified Institutional Buyer
0.15 %
Promoters
Biocon Limited
70.1 %
Biocon Limited Employee Welfare Trust (Murali Krishnan K N And Amitava Saha)
0.32 %
Yamini R Mazumdar
0.01 %
Others
Increase    Decrease    No change
Company Profile Detailed
The company is a contract research, development, and manufacturing services company that offers a broad range of scientific services from the earliest stages of discovery to commercial supplies. This positions the Company as an end-to-end service provider within its sector.
Belongs to (32 Indices) view more
Investors (435)
mahesh.g...
ajit.man...
ramakris...
Followers (15)
yogesh
nitin2
keerthi